99 related articles for article (PubMed ID: 1522353)
1. The prevalence of vascular occlusive disease associated with antiphospholipid syndromes.
Bacharach JM; Lie JT; Homburger HA
Int Angiol; 1992; 11(1):51-6. PubMed ID: 1522353
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies among anti-U1-70 kDa autoantibody positive patients with mixed connective tissue disease.
Komatireddy GR; Wang GS; Sharp GC; Hoffman RW
J Rheumatol; 1997 Feb; 24(2):319-22. PubMed ID: 9034990
[TBL] [Abstract][Full Text] [Related]
5. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
6. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin antibodies and lupus anticoagulant in Chinese patients with systemic lupus erythematosus.
Wong KL; Liu HW; Ho K; Chan K; Wong R
J Rheumatol; 1991 Aug; 18(8):1187-92. PubMed ID: 1941822
[TBL] [Abstract][Full Text] [Related]
8. Association of lupus anticoagulant and anticardiolipin antibodies with thrombosis in patients with systemic lupus erythematosus, primary antiphospholipid syndrome and other disorders.
Brenner B; Tavori S; Lerner M; Tatarsky I; Lorber M
Isr J Med Sci; 1992 Jan; 28(1):9-15. PubMed ID: 1733904
[TBL] [Abstract][Full Text] [Related]
9. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of thrombosis in secondary antiphospholipid-protein syndrome].
Swadźba J; Musiał J; Jankowski M; Grzywacz M; Szczeklik A
Pol Merkur Lekarski; 1996 Nov; 1(5):310-2. PubMed ID: 9273202
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE.
Meyer O; Piette JC; Bourgeois P; Fallas P; Bletry O; Jungers P; Kahn MF; Godeau P; Ryckewaert A
J Rheumatol; 1987 Jun; 14(3):502-6. PubMed ID: 3114485
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
13. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus.
Somers E; Magder LS; Petri M
J Rheumatol; 2002 Dec; 29(12):2531-6. PubMed ID: 12465147
[TBL] [Abstract][Full Text] [Related]
14. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
17. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
18. [Clinical manifestations correlated with anticardiolipin antibodies in systemic lupus erythematosus: preliminary results of a prospective study].
Galeazzi M; Sebastiani GD; Passiu G; Bellucci AM; Porzio F
Medicina (Firenze); 1990; 10(4):403-5. PubMed ID: 2099983
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome.
Gezer S
Dis Mon; 2003 Dec; 49(12):696-741. PubMed ID: 14679358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
